Laura Hurley
Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 45 | 2026 | 1406 | 4.100 |
Why?
| | Physicians, Primary Care | 16 | 2024 | 207 | 3.900 |
Why?
| | Practice Patterns, Physicians' | 25 | 2024 | 1319 | 2.370 |
Why?
| | Attitude of Health Personnel | 28 | 2024 | 1168 | 2.280 |
Why?
| | Influenza Vaccines | 16 | 2025 | 515 | 2.150 |
Why?
| | Vaccines | 14 | 2025 | 386 | 2.080 |
Why?
| | Pneumococcal Vaccines | 7 | 2025 | 129 | 2.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 13 | 2025 | 1389 | 2.030 |
Why?
| | Herpes Zoster Vaccine | 7 | 2022 | 154 | 1.880 |
Why?
| | Physicians, Family | 11 | 2021 | 174 | 1.540 |
Why?
| | Vaccination Coverage | 4 | 2026 | 102 | 1.490 |
Why?
| | Influenza, Human | 11 | 2023 | 608 | 1.370 |
Why?
| | Herpes Zoster | 4 | 2022 | 315 | 1.330 |
Why?
| | Health Care Surveys | 13 | 2021 | 533 | 1.190 |
Why?
| | Immunization | 8 | 2021 | 374 | 1.090 |
Why?
| | Self Report | 6 | 2026 | 861 | 1.080 |
Why?
| | Papillomavirus Vaccines | 8 | 2021 | 298 | 0.980 |
Why?
| | Surveys and Questionnaires | 24 | 2025 | 5954 | 0.960 |
Why?
| | Immunization Schedule | 9 | 2021 | 187 | 0.880 |
Why?
| | Immunization, Secondary | 1 | 2025 | 90 | 0.880 |
Why?
| | Physicians | 10 | 2022 | 925 | 0.840 |
Why?
| | Primary Health Care | 10 | 2024 | 1752 | 0.840 |
Why?
| | Papillomavirus Infections | 5 | 2021 | 352 | 0.820 |
Why?
| | Vaccines, Synthetic | 3 | 2026 | 140 | 0.790 |
Why?
| | Respiratory Syncytial Virus Vaccines | 2 | 2025 | 39 | 0.780 |
Why?
| | Guideline Adherence | 4 | 2024 | 562 | 0.770 |
Why?
| | Adult | 49 | 2026 | 39755 | 0.730 |
Why?
| | Asthma | 6 | 2025 | 1906 | 0.730 |
Why?
| | Pediatricians | 7 | 2022 | 122 | 0.730 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2025 | 136 | 0.720 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 4 | 2019 | 91 | 0.720 |
Why?
| | Respiratory Function Tests | 1 | 2024 | 565 | 0.720 |
Why?
| | General Practitioners | 2 | 2021 | 24 | 0.690 |
Why?
| | Internal Medicine | 5 | 2014 | 275 | 0.680 |
Why?
| | Reminder Systems | 3 | 2018 | 146 | 0.660 |
Why?
| | Middle Aged | 43 | 2026 | 35226 | 0.650 |
Why?
| | Insurance, Health, Reimbursement | 4 | 2018 | 92 | 0.650 |
Why?
| | Vaccination Refusal | 5 | 2021 | 64 | 0.640 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 100 | 0.590 |
Why?
| | United States | 37 | 2026 | 15499 | 0.560 |
Why?
| | Family Practice | 10 | 2017 | 415 | 0.550 |
Why?
| | Humans | 83 | 2026 | 142694 | 0.540 |
Why?
| | Pneumococcal Infections | 2 | 2018 | 104 | 0.530 |
Why?
| | Immunization Programs | 6 | 2020 | 190 | 0.530 |
Why?
| | Female | 53 | 2026 | 76894 | 0.500 |
Why?
| | Practice Guidelines as Topic | 8 | 2024 | 1521 | 0.500 |
Why?
| | Male | 47 | 2026 | 71079 | 0.470 |
Why?
| | Clinical Competence | 3 | 2018 | 1219 | 0.450 |
Why?
| | Aged | 20 | 2026 | 25298 | 0.450 |
Why?
| | Preventive Health Services | 1 | 2016 | 152 | 0.410 |
Why?
| | Data Mining | 2 | 2025 | 117 | 0.410 |
Why?
| | Pediatrics | 11 | 2021 | 1073 | 0.410 |
Why?
| | Insurance, Health | 1 | 2016 | 294 | 0.390 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1084 | 0.390 |
Why?
| | Hepatitis A | 2 | 2026 | 29 | 0.370 |
Why?
| | Meningococcal Vaccines | 3 | 2018 | 58 | 0.360 |
Why?
| | Mumps | 2 | 2022 | 22 | 0.350 |
Why?
| | Anti-Asthmatic Agents | 2 | 2025 | 274 | 0.330 |
Why?
| | Health Services Research | 2 | 2018 | 393 | 0.320 |
Why?
| | Medicare Part D | 1 | 2010 | 23 | 0.320 |
Why?
| | Age Factors | 8 | 2021 | 3266 | 0.310 |
Why?
| | Hepatitis B Vaccines | 2 | 2026 | 42 | 0.310 |
Why?
| | Hepatitis B | 2 | 2026 | 68 | 0.300 |
Why?
| | Electronic Health Records | 4 | 2026 | 1165 | 0.300 |
Why?
| | Young Adult | 10 | 2026 | 13817 | 0.300 |
Why?
| | Clinical Decision-Making | 3 | 2021 | 343 | 0.300 |
Why?
| | Rotavirus Vaccines | 3 | 2021 | 37 | 0.290 |
Why?
| | Nephrology | 1 | 2009 | 60 | 0.280 |
Why?
| | Neuralgia, Postherpetic | 1 | 2008 | 39 | 0.270 |
Why?
| | Gynecology | 3 | 2019 | 174 | 0.270 |
Why?
| | Minority Groups | 1 | 2010 | 278 | 0.270 |
Why?
| | Rotavirus Infections | 2 | 2021 | 35 | 0.270 |
Why?
| | Adverse Drug Reaction Reporting Systems | 2 | 2025 | 80 | 0.260 |
Why?
| | Colorado | 6 | 2026 | 4569 | 0.260 |
Why?
| | Cross-Sectional Studies | 6 | 2026 | 5726 | 0.250 |
Why?
| | Adrenal Cortex Hormones | 3 | 2025 | 498 | 0.250 |
Why?
| | Hepatitis A Vaccines | 1 | 2026 | 20 | 0.240 |
Why?
| | Safety-net Providers | 2 | 2025 | 124 | 0.240 |
Why?
| | Emigrants and Immigrants | 1 | 2009 | 154 | 0.240 |
Why?
| | Medicaid | 3 | 2025 | 453 | 0.230 |
Why?
| | Meningococcal Infections | 2 | 2018 | 26 | 0.230 |
Why?
| | Vaccines, Conjugate | 2 | 2018 | 60 | 0.220 |
Why?
| | Adolescent | 14 | 2026 | 22136 | 0.220 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2020 | 419 | 0.210 |
Why?
| | Professional-Family Relations | 2 | 2016 | 150 | 0.210 |
Why?
| | Physician-Patient Relations | 3 | 2019 | 581 | 0.200 |
Why?
| | Health Expenditures | 1 | 2025 | 189 | 0.200 |
Why?
| | Tinnitus | 1 | 2024 | 65 | 0.200 |
Why?
| | Kidney Failure, Chronic | 1 | 2009 | 595 | 0.190 |
Why?
| | Respiratory Syncytial Virus, Human | 2 | 2025 | 82 | 0.190 |
Why?
| | Beclomethasone | 1 | 2022 | 9 | 0.180 |
Why?
| | Pregnancy | 7 | 2026 | 7129 | 0.180 |
Why?
| | Child | 16 | 2026 | 22376 | 0.180 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2022 | 53 | 0.180 |
Why?
| | Rubella | 1 | 2022 | 22 | 0.180 |
Why?
| | Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.180 |
Why?
| | Measles | 1 | 2022 | 44 | 0.170 |
Why?
| | Herpesvirus 3, Human | 2 | 2019 | 333 | 0.170 |
Why?
| | Rural Population | 1 | 2025 | 613 | 0.170 |
Why?
| | Refusal to Treat | 1 | 2020 | 16 | 0.160 |
Why?
| | Insurance Coverage | 3 | 2018 | 235 | 0.160 |
Why?
| | Standing Orders | 1 | 2020 | 10 | 0.160 |
Why?
| | Norovirus | 1 | 2020 | 22 | 0.150 |
Why?
| | Advisory Committees | 1 | 2021 | 206 | 0.150 |
Why?
| | Policy | 1 | 2020 | 147 | 0.150 |
Why?
| | Gastroenteritis | 1 | 2020 | 62 | 0.150 |
Why?
| | Obstetrics | 2 | 2019 | 172 | 0.150 |
Why?
| | Evidence-Based Medicine | 2 | 2020 | 705 | 0.150 |
Why?
| | Cost of Illness | 2 | 2018 | 315 | 0.140 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2020 | 153 | 0.140 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2095 | 0.130 |
Why?
| | Administration, Inhalation | 3 | 2025 | 592 | 0.130 |
Why?
| | Professional Practice | 1 | 2018 | 58 | 0.130 |
Why?
| | Awareness | 1 | 2018 | 106 | 0.130 |
Why?
| | Glucocorticoids | 1 | 2022 | 539 | 0.130 |
Why?
| | Patients | 1 | 2018 | 176 | 0.130 |
Why?
| | Infant | 8 | 2026 | 9849 | 0.120 |
Why?
| | Health Plan Implementation | 1 | 2018 | 140 | 0.120 |
Why?
| | Information Systems | 1 | 2016 | 59 | 0.120 |
Why?
| | Physician's Role | 2 | 2019 | 216 | 0.120 |
Why?
| | Quality of Life | 3 | 2023 | 3068 | 0.120 |
Why?
| | Directive Counseling | 1 | 2016 | 46 | 0.120 |
Why?
| | Text Messaging | 1 | 2018 | 174 | 0.120 |
Why?
| | Parents | 4 | 2021 | 1407 | 0.110 |
Why?
| | Treatment Refusal | 1 | 2015 | 93 | 0.110 |
Why?
| | Self-Management | 1 | 2018 | 204 | 0.110 |
Why?
| | Attitude to Health | 1 | 2017 | 435 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2018 | 513 | 0.100 |
Why?
| | Patient Acceptance of Health Care | 3 | 2016 | 866 | 0.100 |
Why?
| | Medicare | 2 | 2018 | 813 | 0.100 |
Why?
| | Documentation | 1 | 2015 | 194 | 0.100 |
Why?
| | Health Care Costs | 1 | 2017 | 414 | 0.100 |
Why?
| | Neoplastic Stem Cells | 1 | 2017 | 407 | 0.100 |
Why?
| | Health Surveys | 2 | 2018 | 506 | 0.100 |
Why?
| | Medically Uninsured | 1 | 2014 | 129 | 0.100 |
Why?
| | Tumor Microenvironment | 1 | 2017 | 732 | 0.100 |
Why?
| | Aged, 80 and over | 3 | 2025 | 8009 | 0.090 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 198 | 0.090 |
Why?
| | Neisseria meningitidis | 1 | 2011 | 23 | 0.090 |
Why?
| | Fibroblasts | 1 | 2017 | 1028 | 0.090 |
Why?
| | Safety | 1 | 2013 | 352 | 0.080 |
Why?
| | Fees, Pharmaceutical | 1 | 2010 | 8 | 0.080 |
Why?
| | Product Surveillance, Postmarketing | 2 | 2025 | 68 | 0.080 |
Why?
| | Data Collection | 4 | 2014 | 632 | 0.070 |
Why?
| | Internet | 2 | 2019 | 695 | 0.070 |
Why?
| | Mexican Americans | 1 | 2010 | 114 | 0.070 |
Why?
| | ROC Curve | 1 | 2010 | 605 | 0.070 |
Why?
| | Referral and Consultation | 1 | 2014 | 823 | 0.070 |
Why?
| | Regression Analysis | 2 | 2020 | 995 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 917 | 0.070 |
Why?
| | Electronic Mail | 2 | 2018 | 62 | 0.060 |
Why?
| | Costs and Cost Analysis | 2 | 2018 | 214 | 0.060 |
Why?
| | Health Personnel | 3 | 2019 | 733 | 0.060 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1286 | 0.060 |
Why?
| | Child, Preschool | 4 | 2026 | 11599 | 0.060 |
Why?
| | Hospitalization | 2 | 2026 | 2329 | 0.060 |
Why?
| | Kidney Diseases | 1 | 2009 | 417 | 0.060 |
Why?
| | Renal Dialysis | 1 | 2009 | 459 | 0.050 |
Why?
| | Risk Assessment | 2 | 2015 | 3533 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2083 | 0.050 |
Why?
| | Seasons | 2 | 2020 | 545 | 0.050 |
Why?
| | Vaccines, Combined | 1 | 2023 | 49 | 0.050 |
Why?
| | Nebulizers and Vaporizers | 1 | 2023 | 67 | 0.050 |
Why?
| | Bacterial Vaccines | 1 | 2023 | 63 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 426 | 0.050 |
Why?
| | Symptom Flare Up | 1 | 2022 | 37 | 0.050 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2022 | 47 | 0.050 |
Why?
| | Time Factors | 2 | 2010 | 7010 | 0.040 |
Why?
| | Delivery of Health Care | 1 | 2009 | 937 | 0.040 |
Why?
| | Incidence | 2 | 2024 | 2828 | 0.040 |
Why?
| | Mumps Vaccine | 1 | 2021 | 11 | 0.040 |
Why?
| | Kidney | 1 | 2009 | 1480 | 0.040 |
Why?
| | Risk Factors | 3 | 2010 | 10569 | 0.040 |
Why?
| | Hypertension | 1 | 2009 | 1239 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2021 | 69 | 0.040 |
Why?
| | Vaccines, Attenuated | 1 | 2021 | 130 | 0.040 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2020 | 131 | 0.040 |
Why?
| | Qualitative Research | 2 | 2018 | 1602 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 254 | 0.040 |
Why?
| | Cohort Studies | 2 | 2025 | 5820 | 0.040 |
Why?
| | Pandemics | 2 | 2021 | 1660 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 423 | 0.040 |
Why?
| | Postal Service | 1 | 2018 | 27 | 0.040 |
Why?
| | Serogroup | 1 | 2018 | 44 | 0.040 |
Why?
| | Pharmacists | 1 | 2021 | 239 | 0.030 |
Why?
| | Diphtheria | 1 | 2017 | 21 | 0.030 |
Why?
| | Tetanus | 1 | 2017 | 26 | 0.030 |
Why?
| | Whooping Cough | 1 | 2017 | 55 | 0.030 |
Why?
| | Research Design | 1 | 2024 | 1113 | 0.030 |
Why?
| | Population Groups | 1 | 2017 | 57 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1493 | 0.030 |
Why?
| | Professional Practice Gaps | 1 | 2016 | 13 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 2015 | 33 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 683 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2023 | 2831 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 571 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2017 | 1262 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1655 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 273 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2066 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2930 | 0.020 |
Why?
| | Circovirus | 1 | 2013 | 5 | 0.020 |
Why?
| | Intussusception | 1 | 2013 | 25 | 0.020 |
Why?
| | Life Style | 1 | 2015 | 484 | 0.020 |
Why?
| | Communication | 1 | 2019 | 953 | 0.020 |
Why?
| | Societies, Medical | 1 | 2017 | 862 | 0.020 |
Why?
| | Drug Contamination | 1 | 2013 | 50 | 0.020 |
Why?
| | Decision Support Systems, Clinical | 1 | 2016 | 267 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2026 | 16647 | 0.020 |
Why?
| | Professional Practice Location | 1 | 2011 | 26 | 0.020 |
Why?
| | Community-Institutional Relations | 1 | 2012 | 101 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1066 | 0.020 |
Why?
| | Swine | 1 | 2013 | 837 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2025 | 11341 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4150 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6315 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2017 | 2029 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3558 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5276 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2009 | 221 | 0.020 |
Why?
| | Vascular Diseases | 1 | 2009 | 249 | 0.020 |
Why?
| | Risk-Taking | 1 | 2009 | 332 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2009 | 750 | 0.010 |
Why?
| | Logistic Models | 1 | 2009 | 2088 | 0.010 |
Why?
| | Chronic Disease | 1 | 2009 | 1818 | 0.010 |
Why?
| | Animals | 2 | 2017 | 37909 | 0.010 |
Why?
| | Mice | 1 | 2017 | 18309 | 0.010 |
Why?
|
|
Hurley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|